Pharmaceuticals
Norgine acquires Azanta from European Equity Partners
Dutch pharmaceutical company Norgine had been a minority shareholder of the business since 2014
Gyrus announces new deal, appoints Tobin as partner
Gyrus Capital announces the buyout of Essential Pharma and adds to its team ahead of a new round of fundraising
Bain and Cinven's Stada take-private bid fails
Offer narrowly misses the minimum acceptance condition, with 65.2% of Stada shares tendered
Maven makes 9x on Regent Pacific/Plethora exit
Scottish GP Maven Capital Partners has made 9x money on its investment in London-based premature-ejaculation-focused pharmaceuticals company Regent Pacific, after a full exit.
Atlantic Healthcare raises $24m from LDC et al.
Funding will allow the company to complete phase-3 trials of its inflammatory bowel disease treatment
Forbion Capital leads $15m series-B for Akarna
VC backers plan to invest further to reinforce the company’s growth
Over the counter deals going over private equity's head
Given the high levels of pharmaceutical OTC deals witnessed in the corporate space this year, is PE missing out?
From state monopoly to private equity dominance
Rikke Eckhoff reports on the de-monopolising of the Swedish pharmacy sector